The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Martin J. van den Bent

Neuro-Oncology Unit

Erasmus MC-Daniel den Hoed Cancer Center

PO Box 5201

3008AE Rotterdam

Netherlands

[email]@erasmusmc.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Neuro-Oncology Unit, Erasmus MC-Daniel den Hoed Cancer Center, PO Box 5201, 3008AE Rotterdam, Netherlands. 2005 - 2013
  • Dept Neuro-Oncology and Pathology, Daniel den Hoed Cancer Center and Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands. 2003 - 2010
  • Erasmus Medical Centrum Daniel den Hoed Oncology Center, Rotterdam. 2005
  • Department of Neuro-Oncology, University Hospital Rotterdam/Rotterdam Cancer Center, Netherlands. 2003

References

  1. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. van den Bent, M.J., Brandes, A.A., Taphoorn, M.J., Kros, J.M., Kouwenhoven, M.C., Delattre, J.Y., Bernsen, H.J., Frenay, M., Tijssen, C.C., Grisold, W., Sipos, L., Enting, R.H., French, P.J., Dinjens, W.N., Vecht, C.J., Allgeier, A., Lacombe, D., Gorlia, T., Hoang-Xuan, K. J. Clin. Oncol. (2013) [Pubmed]
  2. IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. van den Bent, M.J., Dubbink, H.J., Marie, Y., Brandes, A.A., Taphoorn, M.J., Wesseling, P., Frenay, M., Tijssen, C.C., Lacombe, D., Idbaih, A., van Marion, R., Kros, J.M., Dinjens, W.N., Gorlia, T., Sanson, M. Clin. Cancer Res. (2010) [Pubmed]
  3. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. van den Bent, M.J., Dubbink, H.J., Sanson, M., van der Lee-Haarloo, C.R., Hegi, M., Jeuken, J.W., Ibdaih, A., Brandes, A.A., Taphoorn, M.J., Frenay, M., Lacombe, D., Gorlia, T., Dinjens, W.N., Kros, J.M. J. Clin. Oncol. (2009) [Pubmed]
  4. Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. van den Bent, M.J., Brandes, A.A., Rampling, R., Kouwenhoven, M.C., Kros, J.M., Carpentier, A.F., Clement, P.M., Frenay, M., Campone, M., Baurain, J.F., Armand, J.P., Taphoorn, M.J., Tosoni, A., Kletzl, H., Klughammer, B., Lacombe, D., Gorlia, T. J. Clin. Oncol. (2009) [Pubmed]
  5. Oligodendroglioma. Van den Bent, M.J., Reni, M., Gatta, G., Vecht, C. Crit. Rev. Oncol. Hematol. (2008) [Pubmed]
  6. Anaplastic oligodendroglioma and oligoastrocytoma. van den Bent, M.J. Neurol. Clin (2007) [Pubmed]
  7. Predictive and prognostic markers in neuro-oncology. van den Bent, M.J., Kros, J.M. J. Neuropathol. Exp. Neurol. (2007) [Pubmed]
  8. Recent developments in the use of chemotherapy in brain tumours. van den Bent, M.J., Hegi, M.E., Stupp, R. Eur. J. Cancer (2006) [Pubmed]
  9. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. van den Bent, M.J., Carpentier, A.F., Brandes, A.A., Sanson, M., Taphoorn, M.J., Bernsen, H.J., Frenay, M., Tijssen, C.C., Grisold, W., Sipos, L., Haaxma-Reiche, H., Kros, J.M., van Kouwenhoven, M.C., Vecht, C.J., Allgeier, A., Lacombe, D., Gorlia, T. J. Clin. Oncol. (2006) [Pubmed]
  10. Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor. van den Bent, M.J. Clin. Cancer Res. (2005) [Pubmed]
  11. Surgical resection improves outcome in metastatic epidural spinal cord compression. van den Bent, M.J. Lancet (2005) [Pubmed]
  12. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. van den Bent, M.J., Afra, D., de Witte, O., Ben Hassel, M., Schraub, S., Hoang-Xuan, K., Malmström, P.O., Collette, L., Piérart, M., Mirimanoff, R., Karim, A.B. Lancet (2005) [Pubmed]
  13. Management of metastatic (parenchymal, leptomeningeal, and epidural) lesions. van den Bent, M.J. Curr. Opin. Oncol (2004) [Pubmed]
  14. Current and future trials of the EORTC brain tumor group. van den Bent, M.J., Stupp, R., Brandes, A.A., Lacombe, D. Onkologie (2004) [Pubmed]
  15. Diagnosis and management of oligodendroglioma. van den Bent, M.J. Semin. Oncol. (2004) [Pubmed]
  16. Advances in the biology and treatment of oligodendrogliomas. van den Bent, M.J. Curr. Opin. Neurol. (2004) [Pubmed]
  17. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. van den Bent, M.J., Taphoorn, M.J., Brandes, A.A., Menten, J., Stupp, R., Frenay, M., Chinot, O., Kros, J.M., van der Rijt, C.C., Vecht, C., Allgeier, A., Gorlia, T. J. Clin. Oncol. (2003) [Pubmed]
  18. The role of chemotherapy in brain metastases. van den Bent, M.J. Eur. J. Cancer (2003) [Pubmed]
  19. European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. van den Bent, M.J., Grisold, W., Frappaz, D., Stupp, R., Desir, J.P., Lesimple, T., Dittrich, C., de Jonge, M.J., Brandes, A., Frenay, M., Carpentier, A.F., Chollet, P., Oliveira, J., Baron, B., Lacombe, D., Schuessler, M., Fumoleau, P. Ann. Oncol. (2003) [Pubmed]
 
WikiGenes - Universities